Cargando…

The associations of psoas and masseter muscles with sarcopenia and related adverse outcomes in older trauma patients: a retrospective study

BACKGROUND: There is an emerging role for radiological evaluation of psoas muscle as a marker of sarcopenia in trauma patients. Older trauma patients are more likely to undergo cranial than abdomino-pelvic imaging. Identifying sarcopenia using masseter cross-sectional area (M-CSA) has shown correlat...

Descripción completa

Detalles Bibliográficos
Autores principales: Varma, Surabhi, Wilson, Michael S. J., Naik, Mitesh, Sandhu, Amandeep, Ota, Helen Chidera Uchenna, Aylwin, Christopher, Fertleman, Michael, Peck, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283168/
https://www.ncbi.nlm.nih.gov/pubmed/35357685
http://dx.doi.org/10.1007/s40520-022-02119-7
_version_ 1784747275222777856
author Varma, Surabhi
Wilson, Michael S. J.
Naik, Mitesh
Sandhu, Amandeep
Ota, Helen Chidera Uchenna
Aylwin, Christopher
Fertleman, Michael
Peck, George
author_facet Varma, Surabhi
Wilson, Michael S. J.
Naik, Mitesh
Sandhu, Amandeep
Ota, Helen Chidera Uchenna
Aylwin, Christopher
Fertleman, Michael
Peck, George
author_sort Varma, Surabhi
collection PubMed
description BACKGROUND: There is an emerging role for radiological evaluation of psoas muscle as a marker of sarcopenia in trauma patients. Older trauma patients are more likely to undergo cranial than abdomino-pelvic imaging. Identifying sarcopenia using masseter cross-sectional area (M-CSA) has shown correlation with mortality. We sought to determine the correlation between psoas: lumbar vertebral index (PLVI) and the M-CSA, and their association with health outcomes. METHODS: Patients aged 65 or above, who presented as a trauma call over a 1-year period were included if they underwent cranial or abdominal CT imaging. Images were retrospectively analysed to obtain PLVI and mean M-CSA measurements. Electronic records were abstracted for outcomes. Logistic regression methods, log scale analyses, Cox regression model and Kaplan–Meier plots were used to determine association of sarcopenia with outcomes. RESULTS: There were 155 eligible patients in the M-CSA group and 204 patients in the PLVI group. Sarcopenia was defined as the lowest quartile in each group. Pearson’s correlation indicated a weakly positive linear relationship (r = 0.35, p < 0.001) between these. There was no statistical association between M-CSA sarcopenia status and any measured outcomes. Those with PLVI sarcopenia were more likely to die in hospital (adjusted OR 3.38, 95% CI 1.47–9.73, p = 0.006) and at 2 years (adjusted HR 1.90, 95% CI 1.11–3.25, p = 0.02). Only 29% patients with PLVI sarcopenia were discharged home, compared with 58% without sarcopenia (p = 0.001). CONCLUSION: Sarcopenia, defined by PLVI, is predictive of increased in-patient and 2-year mortality. Our study did not support prognostic relevance of M-CSA.
format Online
Article
Text
id pubmed-9283168
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-92831682022-07-16 The associations of psoas and masseter muscles with sarcopenia and related adverse outcomes in older trauma patients: a retrospective study Varma, Surabhi Wilson, Michael S. J. Naik, Mitesh Sandhu, Amandeep Ota, Helen Chidera Uchenna Aylwin, Christopher Fertleman, Michael Peck, George Aging Clin Exp Res Original Article BACKGROUND: There is an emerging role for radiological evaluation of psoas muscle as a marker of sarcopenia in trauma patients. Older trauma patients are more likely to undergo cranial than abdomino-pelvic imaging. Identifying sarcopenia using masseter cross-sectional area (M-CSA) has shown correlation with mortality. We sought to determine the correlation between psoas: lumbar vertebral index (PLVI) and the M-CSA, and their association with health outcomes. METHODS: Patients aged 65 or above, who presented as a trauma call over a 1-year period were included if they underwent cranial or abdominal CT imaging. Images were retrospectively analysed to obtain PLVI and mean M-CSA measurements. Electronic records were abstracted for outcomes. Logistic regression methods, log scale analyses, Cox regression model and Kaplan–Meier plots were used to determine association of sarcopenia with outcomes. RESULTS: There were 155 eligible patients in the M-CSA group and 204 patients in the PLVI group. Sarcopenia was defined as the lowest quartile in each group. Pearson’s correlation indicated a weakly positive linear relationship (r = 0.35, p < 0.001) between these. There was no statistical association between M-CSA sarcopenia status and any measured outcomes. Those with PLVI sarcopenia were more likely to die in hospital (adjusted OR 3.38, 95% CI 1.47–9.73, p = 0.006) and at 2 years (adjusted HR 1.90, 95% CI 1.11–3.25, p = 0.02). Only 29% patients with PLVI sarcopenia were discharged home, compared with 58% without sarcopenia (p = 0.001). CONCLUSION: Sarcopenia, defined by PLVI, is predictive of increased in-patient and 2-year mortality. Our study did not support prognostic relevance of M-CSA. Springer International Publishing 2022-03-31 2022 /pmc/articles/PMC9283168/ /pubmed/35357685 http://dx.doi.org/10.1007/s40520-022-02119-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Varma, Surabhi
Wilson, Michael S. J.
Naik, Mitesh
Sandhu, Amandeep
Ota, Helen Chidera Uchenna
Aylwin, Christopher
Fertleman, Michael
Peck, George
The associations of psoas and masseter muscles with sarcopenia and related adverse outcomes in older trauma patients: a retrospective study
title The associations of psoas and masseter muscles with sarcopenia and related adverse outcomes in older trauma patients: a retrospective study
title_full The associations of psoas and masseter muscles with sarcopenia and related adverse outcomes in older trauma patients: a retrospective study
title_fullStr The associations of psoas and masseter muscles with sarcopenia and related adverse outcomes in older trauma patients: a retrospective study
title_full_unstemmed The associations of psoas and masseter muscles with sarcopenia and related adverse outcomes in older trauma patients: a retrospective study
title_short The associations of psoas and masseter muscles with sarcopenia and related adverse outcomes in older trauma patients: a retrospective study
title_sort associations of psoas and masseter muscles with sarcopenia and related adverse outcomes in older trauma patients: a retrospective study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283168/
https://www.ncbi.nlm.nih.gov/pubmed/35357685
http://dx.doi.org/10.1007/s40520-022-02119-7
work_keys_str_mv AT varmasurabhi theassociationsofpsoasandmassetermuscleswithsarcopeniaandrelatedadverseoutcomesinoldertraumapatientsaretrospectivestudy
AT wilsonmichaelsj theassociationsofpsoasandmassetermuscleswithsarcopeniaandrelatedadverseoutcomesinoldertraumapatientsaretrospectivestudy
AT naikmitesh theassociationsofpsoasandmassetermuscleswithsarcopeniaandrelatedadverseoutcomesinoldertraumapatientsaretrospectivestudy
AT sandhuamandeep theassociationsofpsoasandmassetermuscleswithsarcopeniaandrelatedadverseoutcomesinoldertraumapatientsaretrospectivestudy
AT otahelenchiderauchenna theassociationsofpsoasandmassetermuscleswithsarcopeniaandrelatedadverseoutcomesinoldertraumapatientsaretrospectivestudy
AT aylwinchristopher theassociationsofpsoasandmassetermuscleswithsarcopeniaandrelatedadverseoutcomesinoldertraumapatientsaretrospectivestudy
AT fertlemanmichael theassociationsofpsoasandmassetermuscleswithsarcopeniaandrelatedadverseoutcomesinoldertraumapatientsaretrospectivestudy
AT peckgeorge theassociationsofpsoasandmassetermuscleswithsarcopeniaandrelatedadverseoutcomesinoldertraumapatientsaretrospectivestudy
AT varmasurabhi associationsofpsoasandmassetermuscleswithsarcopeniaandrelatedadverseoutcomesinoldertraumapatientsaretrospectivestudy
AT wilsonmichaelsj associationsofpsoasandmassetermuscleswithsarcopeniaandrelatedadverseoutcomesinoldertraumapatientsaretrospectivestudy
AT naikmitesh associationsofpsoasandmassetermuscleswithsarcopeniaandrelatedadverseoutcomesinoldertraumapatientsaretrospectivestudy
AT sandhuamandeep associationsofpsoasandmassetermuscleswithsarcopeniaandrelatedadverseoutcomesinoldertraumapatientsaretrospectivestudy
AT otahelenchiderauchenna associationsofpsoasandmassetermuscleswithsarcopeniaandrelatedadverseoutcomesinoldertraumapatientsaretrospectivestudy
AT aylwinchristopher associationsofpsoasandmassetermuscleswithsarcopeniaandrelatedadverseoutcomesinoldertraumapatientsaretrospectivestudy
AT fertlemanmichael associationsofpsoasandmassetermuscleswithsarcopeniaandrelatedadverseoutcomesinoldertraumapatientsaretrospectivestudy
AT peckgeorge associationsofpsoasandmassetermuscleswithsarcopeniaandrelatedadverseoutcomesinoldertraumapatientsaretrospectivestudy